A Natural History Study of Canavan Disease

NCT02851563 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2019-11-01

No results posted yet for this study

Summary

The purpose of this study is to learn more about the natural history of Canavan disease

Conditions

  • Canavan Disease

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER
  • NYU Langone Health

    lead OTHER

Principal Investigators

  • Florian Eichler, MD · Massachusetts General Hospital

Eligibility

Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02851563 on ClinicalTrials.gov